End stage renal disease (ESRD) is associated with substantial morbidity and mortality. Strategies to prevent the renal function decline that can ultimately result in ESRD are essential. The impact of environmental exposures has received relatively little attention in this regard, despite the fact that exposures such as cadmium and lead are known renal toxicants that are stored long-term in the body and ubiquitous in humans. In fact, the lead and cadmium dose-effect curves for renal function remain uncertain for the low to moderate range of doses. The proposed study will investigate a broad set of causes of renal function decline, including lead, cadmium, blood pressure, diabetes, nephrotoxic medication use, genetic polymorphisms, and age. This application is a competing renewal application of the study """"""""Exposure, dose, body burden, and health effects of lead"""""""" (Schwartz BS, PI) conducted from 1997-2001. It will build on data, from the large cohort of current and former lead workers and participants without occupational lead exposure in the originally funded grant. Study subjects have a wide range of lead exposure and dose measures and renal outcome data from three visits each over an average of 2.2 years. Analysis of existing data has already provided very important results, including longitudinal decline in renal function associated with lead dose measures; interaction between age and lead dose on renal function and renal function decline; interaction between ALAD genotype and lead dose on renal function; and associations of environmental level cadmium dose with elevated NAG in a subset of lead workers. However, in order to better understand the causes of renal function decline, cadmium dose must be characterized in all subjects, additional genotypes must be measured, and additional follow-up time is needed because of the slow rate of renal function decline. We propose to include 675 participants from the first study and enroll 225 new current or former lead workers over age 45 years, those at greater risk for renal function decline. We will obtain blood and tibia lead, genotyping, urinary cadmium, BUN, serum creatinine, measured and calculated creatinine clearances, NAG and RBP during 3 evaluations at yearly intervals.
The specific aims are to determine: 1) if lead and cadmium dose are or continue to be associated with renal function at cross-section and longitudinally; 2) if there is effect modification by lead or cadmium dose, respectively, on associations between cadmium or lead dose and renal function decline; 3) if hypertension modifies the relations of lead or cadmium dose with renal function decline; and 4) whether polymorphisms in the genes for ALAD, VDR, ACE, and eNOS modify or continue to modify relations of lead and/or cadmium dose with renal outcomes. We believe the proposed work will allow a more complete understanding of the causes of renal function decline and lead to the development of public health interventions to prevent this considerable public health problem.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-SOH (01))
Program Officer
Gray, Kimberly A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Public Health & Prev Medicine
Schools of Public Health
United States
Zip Code
Shelley, Rebecca; Kim, Nam-Soo; Parsons, Patrick J et al. (2014) Uranium associations with kidney outcomes vary by urine concentration adjustment method. J Expo Sci Environ Epidemiol 24:58-64
Shelley, Rebecca; Kim, Nam-Soo; Parsons, Patrick J et al. (2014) Associations of multiple metals with kidney outcomes in lead workers: author response. Occup Environ Med 71:154
Shelley, Rebecca; Kim, Nam-Soo; Parsons, Patrick et al. (2012) Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med 69:727-35
Spector, June T; Navas-Acien, Ana; Fadrowski, Jeffrey et al. (2011) Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol Dial Transplant 26:2786-92
Weaver, Virginia M; Kim, Nam-Soo; Jaar, Bernard G et al. (2011) Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med 68:250-6
Weaver, Virginia M; Kim, Nam-Soo; Lee, Byung-Kook et al. (2011) Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ Res 111:1236-42
Tellez-Plaza, Maria; Navas-Acien, Ana; Crainiceanu, Ciprian M et al. (2010) Cadmium and peripheral arterial disease: gender differences in the 1999-2004 US National Health and Nutrition Examination Survey. Am J Epidemiol 172:671-81
Weaver, Virginia M; Griswold, Michael; Todd, Andrew C et al. (2009) Longitudinal associations between lead dose and renal function in lead workers. Environ Res 109:101-7
Navas-Acien, Ana; Tellez-Plaza, Maria; Guallar, Eliseo et al. (2009) Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 170:1156-64
Weaver, Virginia M; Ellis, Lenworth R; Lee, Byung-Kook et al. (2008) Associations between patella lead and blood pressure in lead workers. Am J Ind Med 51:336-43

Showing the most recent 10 out of 17 publications